等待开盘 12-17 09:30:00 美东时间
+0.230
+4.52%
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
12-03 09:58
Lake Street analyst Benjamin Haynor assumes Strata Critical Medical (NASDAQ:SRTA) with a Buy rating and announces Price Target of $8.
12-02 22:58
Strata Critical Medical shares are trading higher after the company reported be...
11-11 01:03
Strata Critical Medical (NASDAQ:SRTA) sees FY2025 sales of $185.000 million-$195.000 million vs $183.828 million analyst estimate.
11-10 21:43
Strata Critical Medical (NASDAQ:SRTA) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.02) by 500 percent. The company reported quarterly sales of $49.298 million which
11-10 20:02
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Strata Critical Medical will release third-quarter 2025 financial results on November 10, 2025, followed by an 8:00 am ET conference call hosted by Melissa Tomkiel and Will Heyburn. Interested participants can register for the call or access an audio-only webcast via the provided links. Strata is a leading provider of time-critical logistics and medical services, serving the U.S. healthcare industry with air transport, surgical organ recovery, an...
10-09 20:16
Strata Critical Medical, Inc., formerly Blade Air Mobility, Inc., will host an Investor Day on November 17, 2025, at the Nasdaq MarketSite in New York City. The event will start at 2:00pm ET and feature presentations by the management team. Investors and analysts can register on Strata’s Investor Relations website. The event will include a live video webcast and presentation materials accessible on ir.stratacrtical.com. Strata is a leading provid...
09-30 20:00
今日重点评级关注:HC Wainwright & Co.:维持Astria Therapeutics"买入"评级,目标价从16美元升至20美元;HC Wainwright & Co.:维持Avalo Therapeutics"买入"评级,目标价从15美元升至25美元
09-18 10:13
Strata Critical Medical has acquired Keystone Perfusion Services for $124 million, combining its capabilities to become the only full-service organ transplant service provider. Keystone, a leading organ recovery and perfusion service provider, contributed $65 million in 2025 revenue and $13 million Adjusted EBITDA. The acquisition includes 88% cash and 12% stock, with potential earn-outs up to $23 million. Keystone's services enhance Strata's off...
09-16 12:30